Literature DB >> 19997118

Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement.

Alexander T Bauer1, Heinrich F Bürgers, Tamer Rabie, Hugo H Marti.   

Abstract

Blood-brain barrier (BBB) disruption, resulting from loss of tight junctions (TJ) and activation of matrix metalloproteinases (MMPs), is associated with edema formation in ischemic stroke. Cerebral edema develops in a phasic manner and consists of both vasogenic and cytotoxic components. Although it is contingent on several independent mechanisms, involving hypoxic and inflammatory responses, the single effect of prolonged hypoxia on BBB integrity in vivo was not addressed so far. Exposing mice to normobaric hypoxia (8% oxygen for 48 h) led to a significant increase in vascular permeability associated with diminished expression of the TJ protein occludin. Immunofluorescence studies revealed that hypoxia resulted in disrupted continuity of occludin and zonula occludens-1 (Zo-1) staining with significant gap formation. Hypoxia increased gelatinolytic activity specifically in vascular structures and gel zymography identified MMP-9 as enzymatic source. Treatment with an MMP inhibitor reduced vascular leakage and attenuated disorganization of TJ. Inhibition of vascular endothelial growth factor (VEGF) attenuated vascular leakage and MMP-9 activation induced by hypoxia. In conclusion, our data suggest that hypoxia-induced edema formation is mediated by MMP-9-dependent TJ rearrangement by a mechanism involving VEGF. Therefore, inhibition of MMP-9 might provide the basis for therapeutic strategies to treat brain edema.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19997118      PMCID: PMC2949161          DOI: 10.1038/jcbfm.2009.248

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

1.  Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia.

Authors:  Y Gasche; J C Copin; T Sugawara; M Fujimura; P H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2001-12       Impact factor: 6.200

2.  Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB.

Authors:  Rachel C Brown; Karen S Mark; Richard D Egleton; Jason D Huber; Amanda R Burroughs; Thomas P Davis
Journal:  J Cell Sci       Date:  2003-02-15       Impact factor: 5.285

3.  Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1.

Authors:  S Fischer; M Wobben; H H Marti; D Renz; W Schaper
Journal:  Microvasc Res       Date:  2002-01       Impact factor: 3.514

4.  Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

Authors:  M Asahi; X Wang; T Mori; T Sumii; J C Jung; M A Moskowitz; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly.

Authors:  W Wang; W L Dentler; R T Borchardt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-01       Impact factor: 4.733

6.  Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia.

Authors:  M Asahi; T Sumii; M E Fini; S Itohara; E H Lo
Journal:  Neuroreport       Date:  2001-09-17       Impact factor: 1.837

7.  Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation.

Authors:  Karen S Mark; Thomas P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-04       Impact factor: 4.733

8.  Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress.

Authors:  Gwen McCaffrey; Colin L Willis; William D Staatz; Nicole Nametz; Carolyn A Quigley; Sharon Hom; Jeffrey J Lochhead; Thomas P Davis
Journal:  J Neurochem       Date:  2009-05-15       Impact factor: 5.372

9.  p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.

Authors:  Katja Issbrücker; Hugo H Marti; Stefan Hippenstiel; Georg Springmann; Robert Voswinckel; Andreas Gaumann; Georg Breier; Hannes C A Drexler; Norbert Suttorp; Matthias Clauss
Journal:  FASEB J       Date:  2002-12-18       Impact factor: 5.191

10.  Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain.

Authors:  Heike J Schoch; Silvia Fischer; Hugo H Marti
Journal:  Brain       Date:  2002-11       Impact factor: 13.501

View more
  124 in total

Review 1.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

2.  The Anti-Edematous Effect of Ghrelin in Brain Hypoxia is Associated with Decreasing Expression of Vascular Endothelial Growth Factor.

Authors:  Gisou Mohaddes; Jalal Abdolalizadeh; Shirin Babri; Naghi Abedini; Fezzeh Hossienzadeh
Journal:  J Mol Neurosci       Date:  2015-03-01       Impact factor: 3.444

3.  Dl-3-n-butylphthalide Attenuates Spinal Cord Injury via Regulation of MMPs and Junction Proteins in Mice.

Authors:  Binbin Zheng; Yanjun Jin; Shuang Mi; Wei Xu; Xiangdong Yang; Zhenghua Hong; Zhangfu Wang
Journal:  Neurochem Res       Date:  2021-06-04       Impact factor: 3.996

Review 4.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Only very early oxygen therapy attenuates posthemorrhagic edema formation and blood-brain barrier disruption in murine intracerebral hemorrhage.

Authors:  Wei Zhou; Marilena Marinescu; Roland Veltkamp
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

Review 6.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

Authors:  Wazir Abdullahi; Dinesh Tripathi; Patrick T Ronaldson
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

Review 7.  Matrix metalloproteinases as therapeutic targets for stroke.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Brain Res       Date:  2015-04-25       Impact factor: 3.252

Review 8.  Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury.

Authors:  Xing-miao Chen; Han-sen Chen; Ming-jing Xu; Jian-gang Shen
Journal:  Acta Pharmacol Sin       Date:  2012-07-30       Impact factor: 6.150

9.  Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia.

Authors:  Changhong Ren; Ning Li; Brian Wang; Yong Yang; Jinhuan Gao; Sijie Li; Yuchuan Ding; Kunlin Jin; Xunming Ji
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

10.  Tissue oxygen is reduced in white matter of spontaneously hypertensive-stroke prone rats: a longitudinal study with electron paramagnetic resonance.

Authors:  John Weaver; Fakhreya Y Jalal; Yi Yang; Jeffrey Thompson; Gary A Rosenberg; Ke J Liu
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-19       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.